Join to view full profile
961 S Gloster StTupelo, MS 38801
Dr. Jain is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amit Jain is an oncologist based in Tupelo, MS. He completed his fellowship in Hematology and Medical Oncology, and his residency in Internal Medicine at the University of Tennessee. Dr. Jain has authored several publications, focusing on topics related to oncology, with his work frequently cited by peers. His recent study on the 27-gene Immuno-Oncology Score and its association with the efficacy of checkpoint immunotherapy in advanced non-small cell lung cancer has been highlighted in notable journals such as Clinical Lung Cancer and BMC Cancer.
Education & Training
University of Tennessee College of MedicineFellowship, Hematology and Medical Oncology, 2020 - 2023- University of Tennessee College of Medicine (Memphis)Residency, Internal Medicine, 2017 - 2020
OtherClass of 2015
Certifications & Licensure
MS State Medical License 2022 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citations27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.David L Saltman, Matthew G Varga, Tyler J Nielsen, Nicole S Croteau, Heather M Lockyer
Clinical Lung Cancer. 2023-03-01 - 10 citationsAssociation of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.Harsha Ranganath, Amit L Jain, Justin R Smith, Julie Ryder, Amina Chaudry
BMC Cancer. 2022-04-14 - 2 citationsRenal Cell Carcinoma Presenting With Combined Cervical Lymphadenopathy and Cardiac Metastasis Without Inferior Vena Cava Involvement.Rana M Usman, Owais Yahya, Hemnishil K. Marella, Amit L Jain, Rahul Peravali
WMJ. 2021-07-01
Journal Articles
- Predictors of Mortality in Metastatic Papillary Renal Cell Cancer• Sidana A, Jain AL (Presenter), Kadakia M, Krane S, Friend J, Muthigi A, Ninos M, Shih J, Srinivasan R., Journal Of Clinical Oncology
- Outcomes with CDK4/6 inhibitors based on endocrine sensitivity in hormone receptor-positive metastatic breast cancer (HR+ MBC)• Jain AL, Mullins JN, Poorman KA, Chaudhry A, Ranganath HA, Miller EM, Valasareddy P, Smith JR, Ryder J, Winerip M, Schwartzberg LS, Vidal GA, Journal of Clinical Oncology, 2019
Abstracts/Posters
- Comparison of End-Fire VS. Side-Fire Ultrasound Probes for MRI/TRUS Fusion-Guided Prostate Biopsy.Jain AL, Sidana A, Stanik Z, Maruf M, Calio B, Sugano D, Gommella P, Hammerich K, Yan P, Turkbey B, Choyke P, Wood B, Pinto P., Society of Urologic Oncology, San Antonio, 11/2017
- Urologist's Practice Patterns And Preferences Regarding Focal Therapy For Prostate Cancer.• Jain A, Sidana A, Sugano D, Calio B, Maruf M, Choyke P, Turkbey B, Wood BJ, Pinto P, AUA, Boston, 5/2017
Research History
- Research ScholarNational Cancer Institute, Bethesda, MD2016 - 2017
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Hindi, Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: